{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:01:14Z","timestamp":1790650874259,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00125-019-4860-y","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T05:38:10Z","timestamp":1556084290000},"page":"1297-1311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia"],"prefix":"10.1007","volume":"62","author":[{"given":"Zexu","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"Albertario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela B.","family":"Sala-Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Emanueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"4860_CR1","doi-asserted-by":"crossref","unstructured":"(2008) The global challenge of diabetes. Lancet 371: 1723","DOI":"10.1016\/S0140-6736(08)60733-3"},{"issue":"9739","key":"4860_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","volume":"376","author":"Faramarz Ismail-Beigi","year":"2010","unstructured":"Ismail-Beigi F, Craven T, Banerji MA et al Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376(9739):419\u2013430. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(10)60576-4","journal-title":"The Lancet"},{"issue":"7","key":"4860_CR3","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.2337\/dc10-0125","volume":"33","author":"R. Pop-Busui","year":"2010","unstructured":"Pop-Busui R, Evans GW, Gerstein HC et al Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 33(7):1578\u20131584. \n                    https:\/\/doi.org\/10.2337\/dc10-0125","journal-title":"Diabetes Care"},{"issue":"4","key":"4860_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2337\/diacare.28.4.956","volume":"28","author":"AJ Boulton","year":"2005","unstructured":"Boulton AJ, Vinik AI, Arezzo JC et al (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28(4):956\u2013962. \n                    https:\/\/doi.org\/10.2337\/diacare.28.4.956","journal-title":"Diabetes Care"},{"issue":"6","key":"4860_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2337\/dc07-1832","volume":"31","author":"CM Reinisch","year":"2008","unstructured":"Reinisch CM, Traxler H, Piringer S, Tangl S, Nader A, Tschachler E (2008) Rarefaction of the peripheral nerve network in diabetic patients is associated with a pronounced reduction of terminal Schwann cells. Diabetes Care 31(6):1219\u20131221. \n                    https:\/\/doi.org\/10.2337\/dc07-1832","journal-title":"Diabetes Care"},{"issue":"2","key":"4860_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/jn.01123.2010","volume":"106","author":"RC Lennertz","year":"2011","unstructured":"Lennertz RC, Medler KA, Bain JL, Wright DE, Stucky CL (2011) Impaired sensory nerve function and axon morphology in mice with diabetic neuropathy. J Neurophysiol 106(2):905\u2013914. \n                    https:\/\/doi.org\/10.1152\/jn.01123.2010","journal-title":"J Neurophysiol"},{"issue":"2","key":"4860_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2217\/fca.10.127","volume":"7","author":"C Feuvre Le","year":"2011","unstructured":"Le Feuvre C, Jacqueminet S, Barthelemy O (2011) Myocardial ischemia: a silent epidemic in type 2 diabetes patients. Futur Cardiol 7(2):183\u2013190. \n                    https:\/\/doi.org\/10.2217\/fca.10.127","journal-title":"Futur Cardiol"},{"issue":"11","key":"4860_CR8","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00125-015-3735-0","volume":"58","author":"Z Dang","year":"2015","unstructured":"Dang Z, Maselli D, Spinetti G et al (2015) Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes. Diabetologia 58(11):2653\u20132662. \n                    https:\/\/doi.org\/10.1007\/s00125-015-3735-0","journal-title":"Diabetologia"},{"issue":"9","key":"4860_CR9","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2337\/dc17-0179","volume":"40","author":"M Jaiswal","year":"2017","unstructured":"Jaiswal M, Divers J, Dabelea D et al (2017) Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 40(9):1226\u20131232. \n                    https:\/\/doi.org\/10.2337\/dc17-0179","journal-title":"Diabetes Care"},{"issue":"6","key":"4860_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/0092-8674(94)90378-6","volume":"76","author":"C Crowley","year":"1994","unstructured":"Crowley C, Spencer SD, Nishimura MC et al (1994) Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76(6):1001\u20131011. \n                    https:\/\/doi.org\/10.1016\/0092-8674(94)90378-6","journal-title":"Cell"},{"issue":"6","key":"4860_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm0696-703","volume":"2","author":"P Anand","year":"1996","unstructured":"Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV (1996) The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 2(6):703\u2013707. \n                    https:\/\/doi.org\/10.1038\/nm0696-703","journal-title":"Nat Med"},{"issue":"22","key":"4860_CR12","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.106.627588","volume":"114","author":"M Ieda","year":"2006","unstructured":"Ieda M, Kanazawa H, Ieda Y et al (2006) Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts. Circulation 114(22):2351\u20132363. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.627588","journal-title":"Circulation"},{"issue":"17","key":"4860_CR13","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1001\/jama.284.17.2215","volume":"284","author":"SC Apfel","year":"2000","unstructured":"Apfel SC, Schwartz S, Adornato BT et al (2000) Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284(17):2215\u20132221. \n                    https:\/\/doi.org\/10.1001\/jama.284.17.2215","journal-title":"JAMA"},{"key":"4860_CR14","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1212\/WNL.54.5.1080","volume":"54","author":"JC McArthur","year":"2000","unstructured":"McArthur JC, Yiannoutsos C, Simpson DM et al (2000) A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 54:1080\u20131088","journal-title":"Neurology"},{"issue":"17","key":"4860_CR15","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1161\/01.CIR.0000033971.56802.C5","volume":"106","author":"C Emanueli","year":"2002","unstructured":"Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P (2002) Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106(17):2257\u20132262. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000033971.56802.C5","journal-title":"Circulation"},{"key":"4860_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00125-004-1424-5","volume":"47","author":"MB Salis","year":"2004","unstructured":"Salis MB, Graiani G, Desortes E, Caldwell RB, Madeddu P, Emanueli C (2004) Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia 47:1055\u20131063","journal-title":"Diabetologia"},{"issue":"7","key":"4860_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/CIRCRESAHA.109.210088","volume":"106","author":"M Meloni","year":"2010","unstructured":"Meloni M, Caporali A, Graiani G et al (2010) Nerve growth factor promotes cardiac repair following myocardial infarction. Circ Res 106(7):1275\u20131284. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.210088","journal-title":"Circ Res"},{"issue":"12","key":"4860_CR18","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/mt.2015.167","volume":"23","author":"M Meloni","year":"2015","unstructured":"Meloni M, Cesselli D, Caporali A et al (2015) Cardiac nerve growth factor overexpression induces bone marrow-derived progenitor cells mobilization and homing to the infarcted heart. Mol Ther 23(12):1854\u20131866. \n                    https:\/\/doi.org\/10.1038\/mt.2015.167","journal-title":"Mol Ther"},{"key":"4860_CR19","first-page":"132","volume":"4","author":"C Chenu","year":"2004","unstructured":"Chenu C (2004) Role of innervation in the control of bone remodeling. J Musculoskelet Nueronal Interact 4:132\u2013134","journal-title":"J Musculoskelet Nueronal Interact"},{"issue":"6","key":"4860_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S8756-3282(99)00215-X","volume":"25","author":"CM Serre","year":"1999","unstructured":"Serre CM, Farlay D, Delmas PD, Chenu C (1999) Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 25(6):623\u2013629. \n                    https:\/\/doi.org\/10.1016\/S8756-3282(99)00215-X","journal-title":"Bone"},{"key":"4860_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuroscience.2014.04.053","volume":"272C","author":"CL Lin","year":"2014","unstructured":"Lin CL, Heron P, Hamann SR, Smith GM (2014) Functional distinction between NGF-mediated plasticity and regeneration of nociceptive axons within the spinal cord. Neuroscience 272C:76\u201387","journal-title":"Neuroscience"},{"issue":"1","key":"4860_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.expneurol.2009.08.025","volume":"223","author":"X Hu","year":"2010","unstructured":"Hu X, Cai J, Yang J, Smith GM (2010) Sensory axon targeting is increased by NGF gene therapy within the lesioned adult femoral nerve. Exp Neurol 223(1):153\u2013165. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2009.08.025","journal-title":"Exp Neurol"},{"issue":"26","key":"4860_CR23","doi-asserted-by":"publisher","first-page":"20358","DOI":"10.1074\/jbc.M109.082834","volume":"285","author":"RS Kenchappa","year":"2010","unstructured":"Kenchappa RS, Tep C, Korade Z et al (2010) p75 neurotrophin receptor-mediated apoptosis in sympathetic neurons involves a biphasic activation of JNK and up-regulation of tumor necrosis factor-alpha-converting enzyme\/ADAM17. J Biol Chem 285(26):20358\u201320368. \n                    https:\/\/doi.org\/10.1074\/jbc.M109.082834","journal-title":"J Biol Chem"},{"issue":"14","key":"4860_CR24","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1161\/CIRCULATIONAHA.111.089763","volume":"125","author":"S Amadesi","year":"2012","unstructured":"Amadesi S, Reni C, Katare R et al (2012) Role for substance p-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects. Circulation 125(14):1774\u20131786. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.089763","journal-title":"Circulation"},{"issue":"2","key":"4860_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/cvr\/cvt153","volume":"100","author":"O Fortunato","year":"2013","unstructured":"Fortunato O, Spinetti G, Specchia C, Cangiano E, Valgimigli M, Madeddu P (2013) Migratory activity of circulating progenitor cells and serum SDF-1alpha predict adverse events in patients with myocardial infarction. Cardiovasc Res 100(2):192\u2013200. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvt153","journal-title":"Cardiovasc Res"},{"issue":"12","key":"4860_CR26","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s00125-006-0401-6","volume":"49","author":"GP Fadini","year":"2006","unstructured":"Fadini GP, Sartore S, Schiavon M et al (2006) Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49(12):3075\u20133084. \n                    https:\/\/doi.org\/10.1007\/s00125-006-0401-6","journal-title":"Diabetologia"},{"key":"4860_CR27","doi-asserted-by":"publisher","first-page":"104ra101","DOI":"10.1126\/scitranslmed.3002191","volume":"3","author":"F Ferraro","year":"2011","unstructured":"Ferraro F, Lymperi S, Mendez-Ferrer S et al (2011) Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 3:104ra101","journal-title":"Sci Transl Med"},{"issue":"2","key":"4860_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.immuni.2012.05.021","volume":"37","author":"C Scheiermann","year":"2012","unstructured":"Scheiermann C, Kunisaki Y, Lucas D et al (2012) Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity 37(2):290\u2013301. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2012.05.021","journal-title":"Immunity"},{"issue":"7258","key":"4860_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321(7258):405\u2013412. \n                    https:\/\/doi.org\/10.1136\/bmj.321.7258.405","journal-title":"BMJ"},{"issue":"3","key":"4860_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/CIRCRESAHA.112.300598","volume":"112","author":"G Spinetti","year":"2013","unstructured":"Spinetti G, Cordella D, Fortunato O et al (2013) Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155\/FOXO3a signaling pathway. Circ Res 112(3):510\u2013522. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.300598","journal-title":"Circ Res"},{"issue":"3","key":"4860_CR31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/ATVBAHA.109.200154","volume":"30","author":"A Oikawa","year":"2010","unstructured":"Oikawa A, Siragusa M, Quaini F et al (2010) Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol 30(3):498\u2013508. \n                    https:\/\/doi.org\/10.1161\/ATVBAHA.109.200154","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"4860_CR32","doi-asserted-by":"publisher","first-page":"30639","DOI":"10.1038\/srep30639","volume":"6","author":"C Reni","year":"2016","unstructured":"Reni C, Mangialardi G, Meloni M, Madeddu P (2016) Diabetes stimulates osteoclastogenesis by acidosis-induced activation of transient receptor potential cation channels. Sci Rep 6(1):30639. \n                    https:\/\/doi.org\/10.1038\/srep30639","journal-title":"Sci Rep"},{"issue":"5","key":"4860_CR33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1182\/blood-2009-05-219923","volume":"115","author":"J Han","year":"2010","unstructured":"Han J, Koh YJ, Moon HR et al (2010) Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells. Blood 115(5):957\u2013964. \n                    https:\/\/doi.org\/10.1182\/blood-2009-05-219923","journal-title":"Blood"},{"issue":"1","key":"4860_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1152\/physrev.00007.2008","volume":"89","author":"A Caporali","year":"2009","unstructured":"Caporali A, Emanueli C (2009) Cardiovascular actions of neurotrophins. Physiol Rev 89(1):279\u2013308. \n                    https:\/\/doi.org\/10.1152\/physrev.00007.2008","journal-title":"Physiol Rev"},{"issue":"3","key":"4860_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0301-0082(02)00016-3","volume":"67","author":"PP Roux","year":"2002","unstructured":"Roux PP, Barker PA (2002) Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 67(3):203\u2013233. \n                    https:\/\/doi.org\/10.1016\/S0301-0082(02)00016-3","journal-title":"Prog Neurobiol"},{"issue":"3","key":"4860_CR36","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1046\/j.1471-4159.2002.00841.x","volume":"81","author":"NT Bui","year":"2002","unstructured":"Bui NT, Konig HG, Culmsee C et al (2002) p75 neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones. J Neurochem 81(3):594\u2013605. \n                    https:\/\/doi.org\/10.1046\/j.1471-4159.2002.00841.x","journal-title":"J Neurochem"},{"issue":"31","key":"4860_CR37","doi-asserted-by":"publisher","first-page":"9903","DOI":"10.1523\/JNEUROSCI.0813-09.2009","volume":"29","author":"E Perlson","year":"2009","unstructured":"Perlson E, Jeong GB, Ross JL et al (2009) A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J Neurosci 29(31):9903\u20139917. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0813-09.2009","journal-title":"J Neurosci"},{"issue":"3","key":"4860_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/cne.10625","volume":"459","author":"B Sorensen","year":"2003","unstructured":"Sorensen B, Tandrup T, Koltzenburg M, Jakobsen J (2003) No further loss of dorsal root ganglion cells after axotomy in p75 neurotrophin receptor knockout mice. J Comp Neurol 459(3):242\u2013250. \n                    https:\/\/doi.org\/10.1002\/cne.10625","journal-title":"J Comp Neurol"},{"key":"4860_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","volume":"50","author":"SC Apfel","year":"2002","unstructured":"Apfel SC (2002) Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol 50:393\u2013413","journal-title":"Int Rev Neurobiol"},{"issue":"7","key":"4860_CR40","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/WNL.57.7.1313","volume":"57","author":"G Schifitto","year":"2001","unstructured":"Schifitto G, Yiannoutsos C, Simpson DM et al (2001) Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology 57(7):1313\u20131316. \n                    https:\/\/doi.org\/10.1212\/WNL.57.7.1313","journal-title":"Neurology"},{"issue":"6","key":"4860_CR41","doi-asserted-by":"publisher","first-page":"10657","DOI":"10.3390\/molecules200610657","volume":"20","author":"N Khan","year":"2015","unstructured":"Khan N, Smith MT (2015) Neurotrophins and neuropathic pain: role in pathobiology. Molecules 20(6):10657\u201310688. \n                    https:\/\/doi.org\/10.3390\/molecules200610657","journal-title":"Molecules"},{"key":"4860_CR42","first-page":"373","volume":"9","author":"DS Chang","year":"2016","unstructured":"Chang DS, Hsu E, Hottinger DG, Cohen SP (2016) Anti-nerve growth factor in pain management: current evidence. J Pain Res 9:373\u2013383","journal-title":"J Pain Res"},{"issue":"1","key":"4860_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10571-009-9430-2","volume":"30","author":"G Cirillo","year":"2010","unstructured":"Cirillo G, Cavaliere C, Bianco MR et al (2010) Intrathecal NGF administration reduces reactive astrocytosis and changes neurotrophin receptors expression pattern in a rat model of neuropathic pain. Cell Mol Neurobiol 30(1):51\u201362. \n                    https:\/\/doi.org\/10.1007\/s10571-009-9430-2","journal-title":"Cell Mol Neurobiol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4860-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T23:06:19Z","timestamp":1587596779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4860-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4860"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4860-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"7 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}